Benzinga | Aug 17, 2021 08:10AM EDT

Morgan Stanley Initiates Coverage On Cytek Biosciences with Equal-Weight Rating, Announces Price Target of $26

Morgan Stanley analyst Tejas Savant initiates coverage on Cytek Biosciences (NASDAQ:CTKB) with a Equal-Weight rating and announces Price Target of $26.